ZEYDOVIO
LIVE

Serial Number

79450596

Owner

ZEALAND PHARMA A/S

Filing Date

Mar 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ZEYDOVIO Trademark

Serial Number: 79450596

ZEYDOVIO is a trademark filed by ZEALAND PHARMA A/S on March 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ZEALAND PHARMA A/S (41 trademarks)

SØBORG 2860 , DK

Entity Type: 03

Trademark Details

Filing Date

March 16, 2026

Registration Date

Not Registered

Goods & Services

Medical and pharmaceutical services, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as Short Bowel Syndrome (SBS); medical and pharmaceutical advice, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as Short Bowel Syndrome (SBS); medical and pharmaceutical services, namely in relation to treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia; medical and pharmaceutical advice, namely in relation to treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia.

Devices for introducing pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as Short Bowel Syndrome (SBS), and parts and fittings therefor; devices for introducing pharmaceutical preparations, namely for treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia, and parts and fittings therefor.

Pharmaceutical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as Short Bowel Syndrome (SBS); medical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as Short Bowel Syndrome (SBS); pharmaceutical preparations, namely for treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia; medical preparations for the treatment of human patients suffering from CHI (Congenital HyperInsulinism) and/or hypoglycemia.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 26, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jun 25, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 3, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 28, 2026 REPR